Antipathogenic surfaces having selenium nanoclusters

US9259005B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9259005-B2
Application numberUS-201113809611-A
CountryUS
Kind codeB2
Filing dateJul 13, 2011
Priority dateJul 13, 2010
Publication dateFeb 16, 2016
Grant dateFeb 16, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is directed to methods for inhibiting growth of pathogens and to substrates with selenium nanoparticles or selenium nanoclusters having antipathogenic properties.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of inhibiting growth of a microbial, bacterial, fungal or yeast pathogen comprising contacting the pathogen to elemental selenium nanoclusters and inhibiting growth of the pathogen. 2. The method of claim 1 wherein the pathogen is on a substrate. 3. The method of claim 2 wherein the substrate includes a metal, a polymer, a ceramic or composites thereof. 4. The method of claim 3 wherein the metal is titanium, aluminum, platinum, niobium, tantalum, tin, nickel, cobalt, chromium, molybdenum, stainless steel, nitinol, Ti6Al4V, SiN, CoCrMo, zinc, silver, gold or alloys thereof. 5. The method of claim 3 wherein the polymer is polycarbonate, polyethyleneimine, isoplast, polyvinyl chloride, silicone, polyurethane, polyether imide, polycaprolactone, poly-lactic-co-glycolic acid, poly-lactic acid, poly-glycolic acid, polyethylene, polyethylene glycol, polydimethylsiloxane, polyacrylamide, polypropylene, polystyrene, polyether ether ketone (PEEK), ultra high molecular weight polyethylene (UHMWPE), hydrogels, or composites thereof. 6. The method of claim 3 wherein the ceramic is alumina, titania, hydroxyapatite, silica, calcium phosphates, bone cements, metal oxides or composites therefore. 7. A method of increasing the antimicrobial, antibacterial, antifungal or anti-yeast properties of a substrate comprising depositing selenium nanoclusters onto a substrate by contacting the substrate with a selenium precursor and a reducing agent for a time sufficient to form selenium nanoclusters on a surface of the substrate. 8. The method of claim 7 wherein the substrate includes a metal, a polymer, a ceramic or composites thereof. 9. The method of claim 8 wherein the metal is titanium, aluminum, platinum, niobium, tantalum, tin, nickel, cobalt, chromium, molybdenum, stainless steel, nitinol, Ti6Al4V, SiN, CoCrMo, zinc, silver, gold or alloys thereof. 10. The method of claim 8 wherein the polymer is polycarbonate, polyethyleneimine, isoplast, polyvinyl chloride, silicone, polyurethane, polyether imide, polycaprolactone, poly-lactic-co-glycolic acid, poly-lactic acid, poly-glycolic acid, polyethylene, polyethylene glycol, polydimethylsiloxane, polyacrylamide, polypropylene, polystyrene, polyether ether ketone (PEEK), ultra high molecular weight polyethylene (UHMWPE), hydrogels, or composites thereof. 11. The method of claim 8 wherein the ceramic is alumina, titania, hydroxyapatite, silica, calcium phosphates, bone cements, metal oxides or composites therefore. 12. The method of claim 7 wherein the selenium precursor is sodium selenite or selenious acid. 13. The method of claim 7 wherein the reducing agent is glutathione, hydrazine, dextrose, ascorbic acid or sodium ascorbate. 14. A method of inhibiting growth of a microbial, bacterial, fungal or yeast pathogen on the surface of a substrate comprising providing the surface of the substrate with elemental selenium nanoclusters, contacting the surface with the pathogen and inhibiting growth of the pathogen on the surface. 15. A method of reducing a microbial, bacterial, fungal or yeast pathogen infection in an animal comprising inserting into the animal a substrate having a surface including elemental selenium nanoclusters, contacting the surface with a microbial, bacterial, fungal or yeast pathogen and inhibiting growth of the pathogen on the surface.

Assignees

Inventors

Classifications

  • Sulfur, selenium or tellurium; Compounds thereof · CPC title

  • Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group · CPC title

  • A01N59/02Primary

    Sulfur; Selenium; Tellurium; Compounds thereof · CPC title

  • Combinations or mixtures of active ingredients covered by classes A01N27/00 - A01N65/48 with other active or formulation relevant ingredients, e.g. specific carrier materials or surfactants, covered by classes A01N25/00 - A01N65/48 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9259005B2 cover?
The present invention is directed to methods for inhibiting growth of pathogens and to substrates with selenium nanoparticles or selenium nanoclusters having antipathogenic properties.
Who is the assignee on this patent?
Webster Thomas J, Tran Phong Anh, Univ Brown
What technology area does this patent fall under?
Primary CPC classification A01N59/02. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).